Literature DB >> 15278100

Chronic central administration of ghrelin reverses the effects of leptin.

M-S Kim1, C Namkoong, H-S Kim, P-G Jang, Y-M Kim Pak, H Katakami, J-Y Park, K-U Lee.   

Abstract

OBJECTIVE: To determine whether chronic central administration of ghrelin can block the effects of leptin on food intake, adiposity, and plasma concentrations of metabolic parameters and hormones.
DESIGN: Intracerebroventricular (ICV) infusions of leptin (5 microg/day) for 7 days, with or without ghrelin (1.2 microg/day), in rats. Rats administered leptin plus ghrelin were divided into ad lib-fed and food-restricted groups. MEASUREMENT: Body weight and food intake were monitored daily. Following killing on day 8, epididymal fat weight and fasting plasma concentrations of glucose, insulin, leptin, ghrelin, IGF-1, and adiponectin were determined.
RESULTS: ICV infusion of leptin decreased food intake by 39% and fat weight by 41%. Leptin decreased plasma concentrations of glucose, insulin, and leptin and increased plasma ghrelin levels. Central coadministration of ghrelin blocked the effects of leptin. Most of the effects of ghrelin were diminished by food restriction but ghrelin effect on adiposity and plasma insulin concentrations remained in food-restricted rats.
CONCLUSION: Chronic central administration of ghrelin reversed the effects of leptin, primarily by altering food intake, but ghrelin may have regulatory effects on adiposity and plasma insulin levels independent of feeding effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278100     DOI: 10.1038/sj.ijo.0802647

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  13 in total

1.  NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake.

Authors:  Erin Keen-Rhinehart; Timothy J Bartness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-01-04       Impact factor: 3.619

2.  Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women.

Authors:  Hikmet Kocak; Yıldız Oner-Iyidogan; Figen Gurdol; Pernur Oner; Deniz Esin
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Ghrelin action in the brain controls adipocyte metabolism.

Authors:  Claudia Theander-Carrillo; Petra Wiedmer; Philippe Cettour-Rose; Ruben Nogueiras; Diego Perez-Tilve; Paul Pfluger; Tamara R Castaneda; Patrick Muzzin; Annette Schürmann; Ildiko Szanto; Matthias H Tschöp; Françoise Rohner-Jeanrenaud
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

Review 4.  Endocrine regulation of bone and energy metabolism in hibernating mammals.

Authors:  Alison H Doherty; Gregory L Florant; Seth W Donahue
Journal:  Integr Comp Biol       Date:  2014-02-19       Impact factor: 3.326

Review 5.  Role of AMP-activated protein kinase in the control of appetite.

Authors:  B Kola
Journal:  J Neuroendocrinol       Date:  2008-04-28       Impact factor: 3.627

6.  Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists.

Authors:  Anna-Sophia Wisser; Piet Habbel; Bertram Wiedenmann; Burghard F Klapp; Hubert Mönnikes; Peter Kobelt
Journal:  Int J Pept       Date:  2010-01-06

7.  Bariatric surgery and type 2 diabetes mellitus: surgically induced remission.

Authors:  Talar Tejirian; Candice Jensen; Erik Dutson
Journal:  J Diabetes Sci Technol       Date:  2008-07

8.  Chronic central administration of Ghrelin increases bone mass through a mechanism independent of appetite regulation.

Authors:  Hyung Jin Choi; Kyoung Ho Ki; Jae-Yeon Yang; Bo Young Jang; Jung Ah Song; Wook-Young Baek; Jung Hee Kim; Jee Hyun An; Sang Wan Kim; Seong Yeon Kim; Jung-Eun Kim; Chan Soo Shin
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors.

Authors:  Kristy M Heppner; Carolin L Piechowski; Anne Müller; Nickki Ottaway; Stephanie Sisley; David L Smiley; Kirk M Habegger; Paul T Pfluger; Richard Dimarchi; Heike Biebermann; Matthias H Tschöp; Darleen A Sandoval; Diego Perez-Tilve
Journal:  Diabetes       Date:  2013-09-23       Impact factor: 9.461

10.  Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving.

Authors:  C L Haass-Koffler; E G Aoun; R M Swift; S M de la Monte; G A Kenna; L Leggio
Journal:  Transl Psychiatry       Date:  2015-09-29       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.